Clinical trials at the Eleanor N. Dana Cancer Center
Consult your medical team to find out whether you are a candidate for one of our clinical trials. Since we are constantly expanding the list of clinical trials we offer, if you don't see your cancer indication listed below please contact the Eleanor N. Dana Cancer Center at 419.383.6644. You can learn more about clinical trials here.
All Cancer Indications
Molecular Target Registry
Head and Neck Cancer
A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head and Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)
Identifier: NCT05077709
Principal Investigator: Danae Hamouda, MD
Prostate Cancer
A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX®
Identifier: NCT05467176
Principal Investigator: Firas Petros, MD
Urothelial (Renal pelvis, Ureter, and Bladder) Cancers
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Identifier: NCT04452591
Principal Investigator: Firas Petros, MD
For more information about the clinical trials that are offered at the Eleanor N. Dana Cancer Center please contact Danielle Mockensturm at 419.383.6925.